Michael Leuchten is an experienced analyst in the field of global medical innovations, currently serving as a Managing Director at Jefferies since 2025. Previously, Michael held analytical positions at notable firms such as UBS Investment Bank, Deutsche Bank, and Barclays Investment Bank, where they specialized in equity research, particularly focusing on EU pharmaceuticals and biotech. Michael earned a Bachelor of Science in Economics with First Class honors from the London School of Economics and Political Science between 1998 and 2001. Prior roles include facing leadership responsibilities at UBS, where they were the Head of EU Pharmaceutical Research from 2020 to 2024.
This person is not in the org chart
This person is not in any teams
This person is not in any offices